Novartis AG (Novartis AG) Other Operating Expense

: $1,005 Mil (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

Novartis AG's Other Operating Expense for the three months ended in Dec. 2023 was $161 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $1,005 Mil.

Novartis AG's quarterly Other Operating Expense declined from Jun. 2023 ($463 Mil) to Sep. 2023 ($197 Mil) and declined from Sep. 2023 ($197 Mil) to Dec. 2023 ($161 Mil).

Novartis AG's annual Other Operating Expense increased from Dec. 2021 ($715 Mil) to Dec. 2022 ($2,568 Mil) but then declined from Dec. 2022 ($2,568 Mil) to Dec. 2023 ($531 Mil).

Novartis AG Other Operating Expense Historical Data

The historical data trend for Novartis AG's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

1,395.00

1,448.00

715.00

2,568.00

531.00

Novartis AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															771.00	184.00	463.00	197.00	161.00

Novartis AG Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,005 Mil.

Novartis AG Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Novartis AG's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.